Mechanism of SSRIs: Monoamine Theory and the Role of BDNF

Mechanism of SSRIs: Monoamine Theory and the Role of BDNF

Mechanism of Action of SSRIs

Overview of the Monoamine Theory of Depression

  • The presentation introduces the mechanism of action for selective serotonin reuptake inhibitors (SSRIs), divided into three sections: the monoamine theory, 5-HT1A receptor downregulation, and BDNF's role in depression.
  • The monoamine theory suggests that depression is linked to decreased serotonergic and noradrenergic neurotransmission.

Limitations of the Monoamine Theory

  • Despite SSRIs blocking serotonin reuptake immediately, antidepressant effects are typically delayed by 2 to 4 weeks, raising questions about this discrepancy.
  • The presentation will explore hypotheses explaining why therapeutic effects are not immediate despite increased neurotransmitter availability.

Role of 5-HT1A Receptor Downregulation

Introduction to Serotonergic Neurons

  • A serotonergic neuron consists of a somatodendritic region, axon, and preoptic terminal; it interacts with postsynaptic neurons.

Functionality of 5-HT1A Receptors

  • The 5-HT1A receptor inhibits firing in serotonergic neurons when stimulated, acting as an autoreceptor that reduces serotonergic activity.

Mechanism Behind SSRI Action

  • SSRIs block the serotonin transporter (SERT), increasing serotonin levels in synaptic spaces. This leads to fewer active 5-HT1A receptors due to downregulation.

Downregulation Process

  • Increased serotonin concentrations result in reduced expression of 5-HT1A receptors over time (weeks), which may explain delayed antidepressant effects.

Consequences of Downregulation on Serotonergic Activity

Disinhibition and Increased Firing Rate

  • With fewer 5-HT1A receptors present, serotonergic neurons become disinhibited, leading to increased firing rates and greater serotonin release into synaptic spaces.

Summary of Mechanism

  • In summary, SSRIs increase serotonin concentration which causes downregulation of 5-HT1A receptors; this disinhibits neurons allowing more serotonin release.

Recent Findings on BDNF's Role in Depression

Neurotrophic Hypothesis

Video description

The Psychopharmacology Institute is an online platform offering unbiased, practical psychopharmacology updates for healthcare providers, with content updated monthly. It also presents opportunities to earn CME and SA credits. This video explains the complex mechanism of selective serotonin reuptake inhibitors (SSRIs), from the monoamine theory of depression and the role of 5HT1A receptor down regulation to the breakthrough findings on the role of brain-derived neurotrophic factor (BDNF) in depression. Understand the link between the molecular action and the clinical effects of these widely used antidepressants. We invite you to visit our website, where you'll find content that allows you to earn CME credits. Take a look at the 2023-24 Psychopharmacology Update here: https://shorturl.at/inqHK #SSRIMechanism #MonoamineTheory #5HT1AReceptor #Psychopharmacology